AIKIDO PHARMA INC (AIKI)
US0088753043 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 38.69M | 69.76M | 2.72M | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | 90.00K | 20.00K | |||
| Marketable Securities | 8.06M | 13.70M | 24.80M | 860.00K | 2.70M | |||
| Receivables | 8.64M | 6.98M | N/A | N/A | N/A | |||
| Other Current Assets | 693.00K | 442.00K | 220.00K | 180.00K | 190.00K | |||
| Total Current Assets | 56.09M | 90.89M | 27.73M | 1.13M | 2.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | 708.00K | N/A | N/A | 0.00 | 0.00 | |||
| Investments And Advances | 26.09M | 9.46M | 2.76M | 10.15M | 10.35M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 458.00K | 155.00K | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 28.36M | 11.77M | 2.77M | 10.15M | 10.34M | |||
| TOTAL ASSETS | 84.45M | 102.66M | 30.50M | 11.28M | 13.25M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.38M | 680.00K | 310.00K | 680.00K | 730.00K | |||
| Accounts Payable | 518.00K | 381.00K | 570.00K | 70.00K | 130.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 290.00K | |||
| Total Current Liabilities | 1.90M | 1.06M | 880.00K | 750.00K | 1.15M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 701.00K | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Liabilities | 701.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 2.60M | 1.06M | 880.00K | 750.00K | 1.15M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -178.63M | -163.77M | -156.60M | -144.27M | -140.08M | |||
| Additional Paid In Capital | 262.97M | 265.62M | 186.48M | 155.06M | 152.44M | |||
| Common Shares | 550.00 | 9.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -2.50M | -264.00K | -260.00K | -260.00K | -260.00K | |||
| Other Shareholders' Equity | -550.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 5.14M | 5.28M | 34.92M | 4.83M | 2.01M | |||
| Tangible Book Value per Share | 15.92 | 19.26 | 0.85 | 2.18 | 6.02 | |||
| Total Shareholders' Equity | 81.85M | 101.59M | 29.62M | 10.53M | 12.10M | |||
| TOTAL LIABILITIES AND EQUITY | 84.45M | 102.66M | 30.50M | 11.28M | 13.25M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 29.54 | 85.66 | 31.51 | 1.51 | 2.53 | |||
| Return On Assets (ROA) | -19.73% | -6.99% | -40.46% | -37.06% | 13.06% | |||
| Return On Equity (ROE) | -20.36% | -7.06% | -41.66% | -39.70% | 14.30% | |||
All data in USD